Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Treatment of the Cystoid Macular Oedema in Behçet's Disease with Interferon Alfa-2a

Deuter C. M. E.1, Kötter I.2, Günaydin I.2, Zierhut M.1, Stübiger N.1
1University Eye Hospital, Dept. I, Tuebingen; 2 University Medical Clinic, Dept. II, Tuebingen

Purpose: Ocular involvement is present in 60-80 % of patients with Behçet's disease (BD). Beside an occlusive vasculitis visual prognosis is limited especially by the cystoid macular oedema which is often refractive to therapy with conventional immunosuppressants. The purpose of this study was to investigate the effect of IFN alfa-2a to the cystoid macular oedema in ocular BD.
Method: We treated 28 patients (female:male = 8:20) suffering from panuveitis or posterior uveitis with uni- or bilateral cystoid macular oedema due to complete BD with IFN alfa-2a (initial dosage 6 Mio. IU per day subcutaneously). Other immunosuppressants were discontinued on the day before start of IFN, steroids were reduced to a maximum dosage of 10 mg prednisolone per day.
Results: At initiation of IFN-therapy 45 eyes showed a cystoid macular oedema proven by fluorescein angiography. In every case there was a complete resorption of macular oedema after a mean of two to four weeks after begin of IFN-treatment without the need for additional application of carboanhydrase inhibitors. Measurements performed by Optical Coherence Tomography (OCT) showed that the effect of IFN to the cystoid macular oedema begins within a few days.
Conclusions: In our study IFN


Zurück | Back